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Introduction
Familial Mediterranean fever (FMF), resulting from
mutations in the MEFV gene, is the most prevalent
genetically determined autoinflammatory disease with
the highest occurrence in the south-eastern Mediterra-
nean’s and Armenia. In central Europe, experience with
FMF is limited, as in Slovakia, where no cases have been
reported, so far.
Objectives
To summarize the experiences with FMF in Slovakia.
Methods
Paediatric rheumatologists were contacted and a search
of local literature was carried out to identify and
collect available retrospective clinical data of patients
with FMF.
Results
5 patients (1 male, 4 female, 2 related, 2 children and
3 adults) diagnosed with FMF based on the clinical pic-
ture and genetic analysis could be identified. Recurrent
episodes of fever, abdominal and thoracic pain were pre-
sent in all patients. Additional symptoms were arthralgia/
arthritis (n = 3), splenomegaly (n = 1), hepatomegaly (n =
1), lymphadenopathy (n = 1) and exanthema (n = 1). In
spite of significant diagnostic delay (4,5 - 30,0 years from
onset of clinical symptoms), no patient has developed
amyloidosis. Only well-known mutations (M694V,
E148Q, V726A, E167D and F479L) were identified. All
patients responded well to colchicine therapy (1 partial, 4
complete response) with good tolerance. Interestingly,
only one patient originated from a high-risk population
(Egypt), all other were of white Slovak native origin.
Conclusion
FMF due to common MEFV mutations does occur in
Slovak low-risk central European population. Due to its
low prevalence and resulting lack of clinical expertize
diagnosis may be significantly delayed, thus exposing
patients to an increased risk of AA amyloidosis. Further
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